Australia markets closed

Accelerate Diagnostics, Inc. (AXDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8820-0.0108 (-1.21%)
At close: 04:00PM EDT
0.9200 +0.04 (+4.31%)
After hours: 06:38PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-59,053
-61,618
-62,493
-77,702
-78,208
Depreciation & amortisation
3,310
3,254
3,000
2,518
2,997
Stock-based compensation
6,129
5,387
10,625
22,047
16,464
Change in working capital
3,670
4,932
1,751
-709
-3,702
Accounts receivable
163
-234
-100
-893
1,592
Inventory
501
446
-236
-415
-1,356
Accounts payable
1,584
295
2,920
273
-1,006
Other working capital
-36,817
-41,231
-49,282
-47,926
-51,756
Other non-cash items
-5,404
-6,926
1,308
11,542
11,168
Net cash provided by operating activities
-35,281
-40,196
-48,728
-47,323
-50,394
Cash flows from investing activities
Investments in property, plant and equipment
-1,536
-1,035
-554
-603
-1,362
Purchases of investments
-
0
-27,506
-30,081
-46,933
Sales/maturities of investments
1,474
9,695
40,477
38,988
61,901
Net cash used for investing activities
-62
8,660
12,417
8,304
13,606
Cash flows from financing activities
Debt repayment
-1,252
-1,250
-1,281
-360
-366
Common stock issued
16,282
4,000
32,872
42,880
359
Other financing activities
-
-3,731
-192
-1,240
-
Net cash used provided by (used for) financing activities
20,535
9,019
31,630
43,226
11,633
Net change in cash
-14,802
-22,767
-4,993
4,117
-25,233
Cash at beginning of period
29,408
34,905
39,898
35,781
61,014
Cash at end of period
14,600
12,138
34,905
39,898
35,781
Free cash flow
Operating cash flow
-35,281
-40,196
-48,728
-47,323
-50,394
Capital expenditure
-1,536
-1,035
-554
-603
-1,362
Free cash flow
-36,817
-41,231
-49,282
-47,926
-51,756